Keyphrases
Infective Endocarditis
100%
Patient Characteristics
31%
Denmark
29%
Endocarditis
25%
Frailty
25%
Hazard Ratio
22%
Surgical Treatment
14%
Microbiological Etiology
13%
Calendar Period
13%
1-year Mortality
12%
Patient Mortality
12%
Transcatheter Aortic Valve Implantation
12%
Valve Surgery
12%
Prognostic Importance
12%
Study Registry
12%
Odds Ratio
12%
Replacement Method
12%
Temporal Trends
12%
Medical Treatment
12%
Aortic Valve Replacement
12%
Recurrent Hospitalization
12%
Clinical Prognosis
12%
Ischemic Stroke
12%
Bacterial Species
12%
Copenhagen City Heart Study
12%
Treatment Patterns
12%
Scan-on-receive (SCORE)
12%
Transcatheter Aortic Valve Replacement
12%
Transient Ischemic Attack
12%
Socioeconomic Status
12%
Advanced Heart Failure Therapies
12%
Risk Markers
12%
Cardiovascular Risk Prediction
12%
Drug Use
12%
Bacteremia
12%
Early Surgery
12%
Antibiotic Therapy
12%
Embolic Event
12%
Coronary Tortuosity
12%
Staphylococcus Aureus
11%
Background Population
9%
Area under the Curve
8%
Acute Decompensated Heart Failure
8%
Integrated Discrimination Improvement
8%
Forced Expiratory Volume in 1 Second (FEV1)
8%
Clinical Outcomes
6%
Frailty Score
6%
Rehospitalization
6%
Cardiovascular Mortality
6%
Algorithm Evaluation
6%
Medicine and Dentistry
Infective Endocarditis
48%
Percutaneous Aortic Valve Replacement
25%
Frailty
25%
Heart Failure
14%
Cardiovascular Disease
14%
Patient Characteristics
14%
Endocarditis
12%
Socioeconomic Status
12%
Cardiovascular Risk
12%
Risk Evaluation
12%
Combination Therapy
12%
Coronary Risk
12%
Aortic Valve Replacement
12%
Surgery
12%
Metabolic Equivalent
12%
Isotopes of Calcium
12%
Cardiac Computed Tomography
12%
Artery
12%
Coronary Computed Tomography Angiography
12%
Computed Tomography Studies
12%
Physical Performance
12%
Hazard Ratio
8%
Odds Ratio
7%
Surgical Mortality
7%
Proportional Hazards Model
7%
Staphylococcus Aureus
7%
Medical Record
6%
Angiography
6%
Population Research
6%
Physical Activity
6%
Univariate Analysis
6%
Clinical Significance
6%
Image Quality
6%
Patient with Hypertension
6%
Risk Stratification
5%
Pharmacology, Toxicology and Pharmaceutical Science
Bacterial Endocarditis
63%
Frailty
25%
Recurrent Disease
16%
Heart Failure
14%
Endocarditis
12%
Cardiovascular Risk
12%
Transient Ischemic Attack
12%
Cardiovascular Disease
12%
Brain Ischemia
12%
Aortic Stenosis
12%
Bacteremia
12%
Risk Evaluation
12%
Coronary Risk
12%
Antibiotic Therapy
12%
Comorbidity
8%
Surgical Mortality
7%
Mortality Rate
5%